Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124475 | SCV000167908 | benign | not specified | 2013-03-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000124475 | SCV000302128 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000355175 | SCV000478599 | likely benign | Ehlers-Danlos syndrome type 7A | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269973 | SCV002554702 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269974 | SCV002554704 | benign | Fibromuscular dysplasia, multifocal | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000124475 | SCV004029905 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004706653 | SCV005228555 | likely benign | not provided | criteria provided, single submitter | not provided |